Unlock instant, AI-driven research and patent intelligence for your innovation.

Composition of artalbic acid derivatives in preparation of anti-rhinitis medicines

A technology for composition and rhinitis, applied in the direction of drug combination, medical preparations containing active ingredients, pharmaceutical formulas, etc., can solve the problems of poor curative effect and ineffectiveness of rhinitis

Inactive Publication Date: 2016-10-26
南京海澳斯生物医药科技有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, antihistamine drugs such as terfenadine or antiallergic drugs such as tranilast and ketotifen are mainly used in the treatment of rhinitis. These drugs have poor or ineffective effects on chronicity and recurrent rhinitis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition of artalbic acid derivatives in preparation of anti-rhinitis medicines
  • Composition of artalbic acid derivatives in preparation of anti-rhinitis medicines
  • Composition of artalbic acid derivatives in preparation of anti-rhinitis medicines

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] The preparation of embodiment 1 compound Artalbic acid

[0013] The preparation method of compound Artalbic acid (I) refers to the literature published by Antonella Maggio et al. (Antonella Maggio et al., 2011. Artalbic acid, a sesquiterpene with an unusual skeleton from Artemisia alba (Asteraceae) from Sicily. Tetrahedron Letters, 52 (2011) 4543–4545) approach.

[0014]

Embodiment 2

[0015] Synthesis of O-bromoethyl derivative (II) of embodiment 2 Artalbic acid

[0016] Compound I (266 mg, 1.00 mmol) was dissolved in 10 mL of benzene, and tetrabutylammonium bromide (TBAB) (0.08 g), 1,2-dibromoethane (3.760 g, 20.00 mmol) and 6 mL of 50% sodium hydroxide solution. The mixture was stirred at 40 °C for 16 h. After 16 hours, the reaction solution was poured into ice water, extracted twice with dichloromethane immediately, and the organic phase solutions were combined. Then the organic phase solution was washed with water and saturated brine for 5 times successively, then dried with anhydrous sodium sulfate, and finally concentrated under reduced pressure to remove the solvent to obtain a crude product. The crude product was purified by silica gel column chromatography (mobile phase: petroleum ether / acetone=100:1.0, v / v), the brown concentrated elution band was collected and the solvent was evaporated to obtain a brown powder of Compound II (272mg, 73%) .

...

Embodiment 3

[0021] The synthesis of the O-(dichloroethylamino) ethyl derivative (III) of embodiment 3 Artalbic acid

[0022] 1. Synthesis of O-(dihydroxyethylamino)ethyl derivatives of Artalbic acid

[0023] Compound II (187 mg, 0.5 mmol) was dissolved in 20 mL of acetonitrile, anhydrous potassium carbonate (690 mg, 5.0 mmol), potassium iodide (252 mg, 1.5 mmol) and diethanolamine (1051 mg, 10 mmol) were added thereto, and the mixture was heated to reflux for 1 h. After the reaction was completed, the reaction solution was poured into 20 mL of ice water, extracted three times with an equal amount of dichloromethane, and the organic phases were combined. The combined organic phases were successively washed with water and saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure to remove the solvent to obtain a crude product. The crude product was purified by silica gel column chromatography (mobile phase: petroleum ether / acetone=100:1.0, v / v), and the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of a composition of O-(dichloro-ethylamino)ethyl of artalbic acid and O-(di(2-methylmercapto-ethyl)amido)ethyl derivatives in anti-rhinitis medicines, relates to the field of organic synthesis and medicinal chemistry, and particularly relates to the composition of O-(dichloro-ethylamino)ethyl of artalbic acid and O-(di(2-methylmercapto-ethyl)amido)ethyl derivatives and application of the composition in preparation of anti-rhinitis medicines. The invention discloses the composition of O-(dichloro-ethylamino)ethyl of artalbic acid and O-(di(2-methylmercapto-ethyl)amido)ethyl derivatives and the preparation method thereof. Pharmacological experiments indicate that the composition of O-(dichloro-ethylamino)ethyl of artalbic acid and O-(di(2-methylmercapto-ethyl)amido)ethyl derivatives has an anti-rhinitis effect, and has a value for developing anti-rhinitis medicines.

Description

technical field [0001] The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to a composition, a preparation method and an application thereof. Background technique [0002] Rhinitis is a common and frequently-occurring disease in clinical practice. The occurrence of rhinitis is mainly related to allergic reactions and belongs to the category of immune inflammation. At present, antihistamine drugs such as terfenadine or antiallergic drugs such as tranilast and ketotifen are mainly used for the treatment of rhinitis, and these drugs have poor or ineffective effects on chronicity and recurrent rhinitis. Therefore, small molecular compounds with clear components, quality control, safety and high efficiency have potential value in the development of drugs for rhinitis treatment. [0003] It is most important to find compounds or lead compounds from natural products and obtain their derivatives through structural modification, so as to o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/195A61P11/02C07C217/12C07C323/25
CPCA61K31/195C07C217/12C07C323/25A61K2300/00
Inventor 丁秋菊
Owner 南京海澳斯生物医药科技有限公司